Alliance Pharma PLC Total Voting Rights (0920L)
September 03 2019 - 9:26AM
UK Regulatory
TIDMAPH
RNS Number : 0920L
Alliance Pharma PLC
03 September 2019
For immediate release 3 September 2019
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Total Voting Rights
Alliance Pharma plc (AIM: APH), the international healthcare
group, makes the following notification in accordance with the UK
Financial Conduct Authority's Disclosure and Transparency Rule
5.6.1.
As at 29 August 2019 the Company's issued share capital consists
of 519,490,041 Ordinary Shares of 1p each.
The total number of voting rights in the Company is 519,490,041
and this figure may be used by shareholders as the denominator for
the calculations by which they should determine if they are
required to notify their interest in, or change to their interest
in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer
www.alliancepharma.co.uk
Buchanan + 44 (0) 20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Freddie Barnfield
Corporate Broking: James Black
Investec Bank plc +44 (0) 20 7597 5970
Corporate Finance: Daniel Adams / Ed Thomas
Corporate Broking: Patrick Robb / Tejas Padalkar
Notes to editors:
About Alliance Pharma
Alliance, founded in 1998, is an international specialty
pharmaceutical group based in Chippenham, Wiltshire, UK. The Group
has sales in more than 100 countries worldwide via direct sales,
joint ventures and a wide network of distributors. Alliance has a
strong track record of acquiring the rights to established niche
products and it currently owns or licenses the rights to
approximately 90 pharmaceutical and consumer healthcare products.
The Group continues to explore opportunities to expand its product
portfolio.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVREALNDEADNEFF
(END) Dow Jones Newswires
September 03, 2019 10:26 ET (14:26 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024